Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans
Authors:
- Ronald J EllisRERonald J Ellis
- Peter SeubertPSPeter Seubert
- Ruth MotterRMRuth Motter
- Douglas GalaskoDGDouglas Galasko
- Reena DeutschRDReena Deutsch
- Robert K HeatonRHRobert K Heaton
- Melvyn P HeyesMHMelvyn P Heyes
- J.Allen McCutchanJMJ.Allen McCutchan
- J Hampton AtkinsonJAJ Hampton Atkinson
- Igor GrantIGIgor Grant
- 1 September 1998
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 254 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patientsNeuroscience Letters, 1997
- Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseNeurology, 1997
- Decreased expression of AMPA receptor messenger RNA and protein in AIDS: A model for HIV-associated neurotoxicityNature Medicine, 1995
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathyActa Neuropathologica, 1995
- The HNRC 500-Neuropsychology of Hiv infection at different disease stagesJournal of the International Neuropsychological Society, 1995
- Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's diseaseNeurology, 1995
- Cerebrospinal fluid (β2-microglobulin in patients with AIDS dementia complexAIDS, 1992
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infectionNeurology, 1991
- (18O)quinolinic acid: Its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acidJournal of Mass Spectrometry, 1988